Supernus Pharmaceuticals SUPN Income Statements

Conto economico

Quarter End	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	167,84M	155,41M	134,77M	154,34M	164,52M	144,74M	172,68M	176,71M
Reddito operativo	32,44M	5,18M	-17,59M	8,14M	-996k	-3,15M	22,57M	40,85M
Reddito ante imposte	35,14M	9,02M	-17,13M	9,89M	990k	243k	26,3M	44,94M
Reddito netto	25,48M	16,95M	-831k	-15,98M	1,18M	124k	19,92M	38,5M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	32,44M	5,18M	-17,59M	8,14M	-996k	-3,15M	22,57M	40,85M
EBITDA	53,85M	25,78M	3,14M	30,03M	40,84M	17,6M	43,29M	60,95M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	215M	302,24M	408,9M	392,76M	520,4M	586,31M	667,75M	609,04M
Reddito operativo	54,22M	99,54M	144,44M	148,57M	173,7M	86,03M	46,12M	-5,27M
Reddito ante imposte	50,37M	100,62M	140,18M	147,49M	168,65M	73,18M	60,74M	2,77M
Reddito netto	91,22M	57,28M	110,99M	113,06M	126,95M	53,42M	60,71M	1,32M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	1.825	1.116	2.122	2.152	2.401	1.003	1.119	0.024
UTILE OPERATIVO	53,53M	99,25M	144,44M	148,57M	173,7M	86,03M	46,12M	-5,27M
EBITDA	56,62M	107,64M	151,54M	155,23M	193,7M	118,62M	131,67M	99,78M